GlassScriptPhysician profile
Robert M Hallivis
NPI 1215938006
$20,515.89
in general payments reported to CMS, 2019-2025
36 companies · $9,045 in 2025
The $9,045 reported for 2025 was more than what 95% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,323 · 2020: $160 · 2021: $326 · 2022: $839 · 2023: $587 · 2024: $8,236 · 2025: $9,045.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,572 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,500 · Food and Beverage: $2,599 · Travel and Lodging: $197.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,571.88 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,500.00 |
| Food and Beverage | $2,599.08 |
| Travel and Lodging | $197.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $8,342.70 | 2024-2025 | |
| Arthrex, INC. | $7,519.18 | 2024-2025 | |
| Wright Medical Technology, INC. | $849.68 | 2019-2020 | |
| Smith+Nephew, INC. | $806.41 | 2019-2025 | Grafix, Stravix, Collagenase Santyl |
| Stryker Corporation | $574.40 | 2019-2024 | Augment Injectable, Bio4, Hoffmann |
| Arteriocyte Medical Systems, INC. | $242.72 | 2024 | Magellan |
| Organogenesis INC. | $203.47 | 2019-2023 | Puraply |
| Integra Lifesciences Corporation | $175.56 | 2019-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Convatec INC. | $166.50 | 2023-2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $162.15 | 2022-2024 | Jublia |
| Biocomposites INC | $159.06 | 2024-2025 | Stimulan |
| Supreme Orthopedic Systems, LLC | $142.08 | 2024-2025 | |
| Paragon 28, INC. | $126.74 | 2023 | Additive Orthopedics |
| Triad Life Sciences INC. | $122.23 | 2022 | |
| Depuy Synthes Sales INC. | $120.76 | 2020-2025 | Healix Knotless Peek, Dynacord |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fusion Orthopedics USA, LLC | $105.26 | 2025 | |
| Kerecis Limited | $88.30 | 2023-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Surgiclose |
| Horizon Therapeutics Plc | $81.54 | 2019-2022 | |
| Paratek Pharmaceuticals, INC. | $60.36 | 2021-2025 | Nuzyra |
| Sandoz INC. | $59.10 | 2019 | |
| Ossio INC | $55.38 | 2023 | |
| Orthofix Medical, INC. | $52.32 | 2020-2025 | Physio-Stim, Spinal-Stim |
| Melinta Therapeutics, LLC | $48.02 | 2019-2022 | |
| Novastep INC. | $43.78 | 2025 | Nexis |
| Medtronic, INC. | $32.20 | 2022-2025 | Inceptiv |
| Amgen INC. | $19.27 | 2024 | Krystexxa |
| Sebela Pharmaceuticals INC. | $19.24 | 2022 | |
| Linvatec Corporation | $18.82 | 2025 | Hercules Suture Anchor System, Allograft Tissue, Hercules Syndesmosis Implant System |
| Averitas Pharma INC. | $17.26 | 2024 | Qutenza |
| Fidia Pharma USA INC. | $16.42 | 2022 | |
| Medartis INC. | $15.88 | 2019 | |
| Reapplix INC. | $15.82 | 2023 | 3c Patch Kit - Box |
| Abbott Laboratories | $13.73 | 2019 | |
| Hartmann USA, INC. | $13.72 | 2025 | Zetuvit Plus 10x10 P10 |
| Heron Therapeutics, INC. | $13.48 | 2021 | |
| Merck Sharp & Dohme LLC | $12.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Hallivis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.